- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine whether R317573, after multiple dosing over one week, reduces the intensity of an anxiogenic reaction induced by the intravenous (i.v.) administration of cholecystokinin-tetrapeptide (CCK-4).
Inclusion criteria
- Anxiety and depression